United States

People: Ironwood Pharmaceuticals Inc (IRWD.O)

IRWD.O on Nasdaq

14 Jun 2019
Change (% chg)

$-0.60 (-5.47%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Consylman, Gina 

Ms. Gina Consylman is the Chief Financial Officer, Senior Vice President of the Company. She has served in her current position at the Company since August 2015, and previously served as the Company’s Vice President, Corporate Controller and Chief Accounting Officer from June 2014 to July 2015. Prior to joining the Company, Ms. Consylman served as Vice President, Corporate Controller and Principal Accounting Officer of Analogic Corporation, a publicly held healthcare and security technology solutions company, from February 2012 to June 2014, where she oversaw Analogic’s global accounting team. Prior to joining Analogic, Ms. Consylman served in various corporate accounting roles at Biogen Inc., a publicly held global biotechnology company, from November 2009 to February 2012, culminating in her service as Senior Director, Corporate Accounting where she was responsible for the accounting teams for the corporate and U.S. commercial business units. Ms. Consylman has also served in various other finance and accounting roles, including Corporate Controller at Varian Semiconductor Equipment Associates, Inc. (subsequently acquired by Applied Materials, Inc.). She also previously held audit positions with PricewaterhouseCoopers LLP and Ernst & Young LLP. Ms. Consylman, a Certified Public Accountant, holds a Bachelor of Science degree in accounting from Johnson & Wales University and a Masters of Science degree in taxation from Bentley College.

Basic Compensation

Total Annual Compensation, USD 519,263
Restricted Stock Awards, USD 440,213
Long-Term Incentive Plans, USD --
All Other, USD 8,040
Fiscal Year Total, USD 967,516

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Peter Hecht


Gina Consylman


Mark Currie


Thomas McCourt


Halley Gilbert


Jon Duane

As Of  30 Dec 2017